EFTA01457562.pdf

II May 2015 Pharmaceuticals GlaxoSmithKline Revised forecasts 'Figure 12; GSK revenue forecasts (Em); key categories/brands (Established Product detail omitted for space reasons) G8Pro FYi4/1 Pr 15E FYIGE P`I'l ?I FY18E FY19E Pel'OF Saccade,Ad...air 4.229 3.662 3.394 3,181 2,694 2,203 017 2,849 ReNar/Breo 67 248 394 552 640 736 AvamysNeramyst 238 241 252 255 259 261 260 Flbrotide/Flovent 702 681 667 628 592 556 522 Ventolin 666 683 704 710 690 672 655 Anoro IUVECNII 17 87 176 280 413 569 728 Mepolizumab 0 39 171 369 655 786 995 Other Respiratory 263 270 301 338 354 374 399 Triple combo 0 0 0 0 24 86 Total flaaptrattay 8.181 6.901 6,068 6.312 0.297 18 6,610 Tota1Oncology 1.202 216 0 0 0 0 0 Avodan 805 759 637 548 446 6.434 1 419 Epsizan laibiglutidel 6 102 160 211 245 263 277 Other CVMU 154 151 148 144 141 138 136 Losmapimod 0 0 0 0 0 6 Total CVMU 966 1,013 946 903 933 836 837 Dermatology 481 446 434 436 447 458 470 Augmentin 573 573 566 563 563 567 560 Other anti-bactetials 215 207 197 188 178 170 161 Benlysta 173 212 296 352 407 411 415 Rare diseases 417 394 406 422 438 454 463 Sirukumab 0 0 10 34 74 132 Retosiban 0 0 0 0 6 21 Talenoquine 0 0 0 0 12 43 'Other other 762 750 746 734 724 717 712 Total other products 2,821 2.602 2.862 2.728 2,831 2.927 3.023 Bocestax 317 332 343 354 365 377 390 COMMIX 118 121 128 137 146 156 166 Fluarix. FluLaval 215 236 247 259 273 287 301 Hepatitis 558 576 694 610 629 648 668 Inlanrix. Pediarix 828 788 820 854 890 928 967 Ramis 376 414 449 498 547 560 673 Synflodx 398 399 402 419 436 454 356 HZ/au 0 0 15 52 111 247 Other Vaccines 382 381 382 397 415 430 442 Ex Novartis vaccines 482 638 662 694 720 738 Total Vaccines 3.192 3.729 3.997 4,232 4,608 4.736 4,917 Innovative Products 14.161 13,451 13.662 14.174 14,469 14,678 15,288 Total VIN Healthcare 1.498 2.0138 2,316 2.552 2,803 2.868 3.032 Total Established 3.011 2.845 2.477 2,263 2,114 2.000 1,898 Total Pharmaceuticals 18.670 18,184 18.466 18.979 19,386 19,546 20.218 Consumer Health 4.338 6.218 6,858 7,126 7,412 7.701 7,999 Group Sales 23,006 24,402 25,313 26,105 28,797 27,247 28,217 San. Mao% SOX *MOM Esnoures Cowry au Deutsche Bank AG/London Page 9 CONFIDENTIAL — PURSUANT TO FED. R CRIM. P. 6(e) DB-SDNY-0117159 CONFIDENTIAL SDNY_GM_00263343 EFTA01457562